A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Clinical trial NCT07592689 · RECRUITING

Trial details

NCT number: NCT07592689
Sponsor: Definium Therapeutics US, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2026-05-10
Primary completion: 2027-09-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.